BioCorRx Inc. announced that it has entered into subscription agreements for a private placement of 342,592 common shares to be issued at a price of $1.75 per share for proceeds of $600,000 on March 29, 2023. The company will also warrant to purchase up to 342,592 shares each, exercisable for three years from the date of issuance at an exercise price of $4 per share. The transaction will include participation from The J and R Galligan Revocable Trust, managed by Joseph Galligan, a member of board of directors of the company and Louis C Lucido and Carolyn M. Lucido, trustees of the Lucido Family Trust for $300,000 each.

The securities are restricted in nature pursuant to regulation D.